Our previous study has shown that overexpression of ECRG2 activates caspases and induces cancer cell death; ECRG2 promotes proteasome-mediated degradation of Hu-antigen R (HuR) oncoprotein, an mRNA-binding protein that is important for regulation of gene expression13. The gene discussed is ELAVL1; the disease is cancer.